Publication | Closed Access
Value of Schwangerschaftsprotein 1 (SP<sub>1</sub>) and pregnancy‐associated plasma protein‐A (PAPP‐A) in the clinical management of threatened abortion
36
Citations
10
References
1983
Year
FertilityReproductive HealthGynecologyPathologyHigh-risk PregnancyReproductive EndocrinologyPregnancy-associated Plasma Protein-aReproductive MedicineObstetricsPublic HealthPlasma Protein‐aVaginal BleedingAtherosclerosisPreeclampsiaInfertilityMaternal Cardiovascular OutcomeMaternal ComplicationMaternal HealthThreatened AbortionSingle Serum SamplesMaternal-fetal MedicineProximity Extension AssayAbortionPregnancyMedicineWomen's HealthSchwangerschaftsprotein 1
Pregnancy-associated plasma protein-A (PAPP-A) and Schwangerschaftsprotein 1 (SP1) levels were measured in single serum samples from 60 patients admitted with vaginal bleeding in the first 14 weeks of pregnancy. When based on ultrasound diagnoses the prediction of non-viability (the predictive value) was 97% for SP1 and 84% for PAPP-A. Whereas the prediction of viability (above -2SD of the normal range) with SP1 was 88% the value with PAPP-A was only 57%; the poorer result obtained with PAPP-A probably reflects its longer half-life. Pregnancy outcome is not related to the duration of bleeding.
| Year | Citations | |
|---|---|---|
Page 1
Page 1